Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The RELEASE Trial: Reconsidering Long-Term Aspirin in the Elderly in Secondary Prevention of Cardiovascular Disease

NCT07795398 is registered in ClinicalTrials.gov with Odense University Hospital as lead sponsor.

NCT NCT07795398
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07795398 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The RELEASE Trial: Reconsidering Long-Term Aspirin in the Elderly in Secondary Prevention of Cardiovascular Disease
Lead sponsor
Odense University Hospital
Phase
Phase 4
Overall status
Recruiting
Start date
September 30, 2026
Completion date
October 31, 2029
Enrollment
7,000 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

aspirin, aspirin causing adverse effects in therapeutic use, chronic coronary syndrome, coronary artery bypass graft, ischemic heart disease, ischemic heart disease chronic, myocardial infarction, non-inferiority trial, percutaneous coronary intervention